Zoetis (ZTS) Short-Term Debt issuances (2013 - 2024)

Zoetis' (ZTS) quarterly Short-Term Debt issuances came in at -$24.0 million in Q2 2024, down 2300.0% year-on-year from $1.1 million in Q3 2023, and down 214.29% on a QoQ basis from $21.0 million in Q1 2024.

Zoetis (ZTS) Short-Term Debt issuances (2013 - 2024) Analysis & Trends

Zoetis (ZTS) has 12 years of Short-Term Debt issuances data on file, last reported at -$24.0 million in Q2 2024.

  • On a quarterly basis, Short-Term Debt issuances fell 2300.0% year-over-year to -$24.0 million in Q2 2024; TTM through Mar 2025 was -$24.0 million, a 214.29% decrease from a year earlier, with the FY2024 full-year figure at -$3.0 million, down 400.0% from the prior year.
  • Short-Term Debt issuances for Q2 2024 stood at -$24.0 million, down from $21.0 million in the prior quarter.
  • Over the last five years, Short-Term Debt issuances for ZTS reached as high as $21.0 million in Q1 2024 and fell as low as -$24.0 million in Q2 2024.
  • Historically, Short-Term Debt issuances has averaged $0.0 across 5 years, with a median of $1.0 million in 2020.
  • On a YoY basis, Short-Term Debt issuances climbed as much as 2000.0% in 2024 and fell as far as 2300.0% in 2024.
  • Year by year, Short-Term Debt issuances stood at $3.0 million in 2020, then slumped by 233.33% to -$4.0 million in 2021, then soared by 75.0% to -$1.0 million in 2022, then jumped by 200.0% to $1.0 million in 2023, then sank by 2500.0% to -$24.0 million in 2024.
  • Per Business Quant data, the three most recent Short-Term Debt issuances figures were -$24.0 million in Q2 2024, $21.0 million in Q1 2024, and $1.0 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt issuances (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2024 -24.00 Mn
Jun 30, 2024 -24.00 Mn
Mar 31, 2024 21.00 Mn
Mar 31, 2024 21.00 Mn
Dec 31, 2023 1.00 Mn
Dec 31, 2023 1.00 Mn
Jun 30, 2023 -1.00 Mn
Jun 30, 2023 -1.00 Mn
Mar 31, 2023 1.00 Mn
Mar 31, 2023 1.00 Mn
Dec 31, 2022 -1.00 Mn
Dec 31, 2022 -1.00 Mn
Sep 30, 2022 1.00 Mn
Sep 30, 2022 1.00 Mn
Jun 30, 2022 2.00 Mn
Jun 30, 2022 2.00 Mn
Sep 30, 2021 -4.00 Mn
Sep 30, 2021 -4.00 Mn
Dec 31, 2020 3.00 Mn
Dec 31, 2020 3.00 Mn